Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal 
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review 
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand 
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue 
CHICAGO, April 02, 2018 -- Today, Allscripts (NASDAQ:MDRX) closed the previously announced sale of its OneContent business to Hyland Software, Inc. Hyland is a leading provider of content services solutions to the healthcare industry and beyond. Allscripts acquired the OneContent business in late 2017 through the acquisition of McKesson’s EIS portfolio.
© 2018 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
Investors:
Dennis Olis
312-386-6700
[email protected]
Media:
Concetta Rasiarmos
312-447-2466
[email protected]
